We believe that through innovation and collaboration, our research can lead to more effective therapies and improve the lives of those affected by neurological and neurodegenerative diseases.
The Brain Repair and Intracranial Neurotherapeutics unit is a group of leading clinicians and scientists who are researching ways to develop and deliver novel cell, drug and growth factor therapies to patients with currently untreatable neurological neurodegenerative diseases.
We focus on 4 main conditions:
BRAIN runs regular events, workshops and activities throughout the year for researchers, patient and members of the public
See what's happeningOur dedicated 4 bed clinical research facility in the University Hospital of Wales is the heart of BRAIN's clinical trial delivery
Learn more24th Sep, 2024
Ataxia is a neurodegenerative condition which affects one in 50,000 people. This is Alan’s story, founder of a charity c...
See more9th Jul, 2024
Dr Chloe Ormonde is a lab technician at the BRAIN Unit. In this piece, Chloe shares her career journey so far and why sh...
See more20th May, 2024
The BRAIN Unit were delighted to support the launch of the new Huntington’s Disease Centre in Wales which took place in...
See more28th Apr, 2024
On Saturday 20 April, BRAIN co-hosted an event with the National Centre for Mental Health (NCMH) to celebrate the import...
See more14th Feb, 2024
The BRAIN Unit and National Centre for Mental Health (NCMH) will co-host an event on Saturday 20 April to celebrate the...
See more10th Jan, 2024
On Thursday 7 December, our BRAIN Involve lead Dr Cheney Drew delivered a public lecture on the use of advanced therapie...
See more20th Nov, 2023
My name is Dr Cheney Drew, and I am a Research Fellow and Senior Clinical Trials Manager based in Centre for Trials Rese...
See more7th Oct, 2023
Wrth i ni symud i ffwrdd oddi wrth heriau COVID, rydym wedi gallu manteisio ar offer ar-lein ac ailddychmygu sut rydym y...
See moreIf you would like to know more about the BRAIN Unit and what we do, please get in touch
Contact us